Tangible Shareholders Equity (Quarterly)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Castle Biosciences, Inc. (CSTL) had Tangible Shareholders Equity of $371.30M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$87.01M
Net Income	$-2.33M
Cost of Goods Sold	$18.32M
Gross Profit	$68.69M
Operating Expenses	$90.84M
Operating Income	$-3.83M
Non-Operating Income/Expense	$1.11M
Pre-Tax Income	$-2.71M
Normalized Pre-Tax Income	$-2.71M
Income after Taxes	$-2.33M
Income from Continuous Operations	$-2.33M
Consolidated Net Income/Loss	$-2.33M
Normalized Income after Taxes	$-2.33M
EBIT	$-3.83M
EBITDA	$-0.76M
Weighted-Average Shares Outstanding (Basic)	28.99M
Weighted-Average Shares Outstanding (Diluted)	28.99M
Earnings per Share (EPS) (Basic)	$-0.07
Earnings per Share (EPS) (Diluted)	$-0.06
Balance Sheet Financials
Current Assets	$361.10M
Property, Plant, and Equipment	$97.44M
Long-Term Assets	$217.46M
Total Assets	$578.56M
Current Liabilities	$68.68M
Long-Term Debt	$9.95M
Long-Term Liabilities	$39.01M
Total Liabilities	$107.68M
Common Equity	$470.87M
Tangible Shareholders Equity	$371.30M
Shareholders Equity	$470.87M
Common Shares Outstanding	29.69M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$64.35M
Cash Flow from Investing Activities	$-60.37M
Cash Flow from Financial Activities	$-6.96M
Beginning Cash	$119.71M
End Cash	$116.73M
Increase/Decrease in Cash	$-2.98M
Stock-Based Compensation	$45.89M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.02
Gross Margin	78.95%
Operating Margin	-4.40%
EBIT Margin	-4.40%
EBITDA Margin	--
Pre-Tax Profit Margin	-3.12%
Profit Margin	-2.68%
Free Cash Flow	$28.37M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	1.79
Receiveable Turnover	2.01
Days Sales in Receivables	44.87
Return on Equity	-0.50%
Return on Tangible Equity	-0.63%
Return on Assets	-0.40%
Return on Investments	-0.48%
Book Value Per Share	$15.86
Free Cash Flow per Share	$0.98
Operating Cash Flow per Share	$2.22

Data from Zacks Investment Research, Inc.